Patents by Inventor Lisa A. Ware

Lisa A. Ware has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Notification escalation based on visual recognition
    Patent number: 11563705
    Abstract: A method can include obtaining notification data for a user, and obtaining a first set of images of the user from one or more cameras. The method can include identifying a first status of the user, and generating a set of notification options based on the first status. The method can include selecting a first notification option, and initiating a first notification by the first notification option. The method can include determining that the user does not acknowledge the first notification, and obtaining a second set of images from the one or more cameras. The method can include identifying a second status of the user, and selecting a second notification option of the set of notification options. The method can include initiating a second notification by the second notification option.
    Type: Grant
    Filed: September 28, 2020
    Date of Patent: January 24, 2023
    Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Lisa Lurie, Steven Ware Jones, Jennifer A. Mallette
  • VISUAL RECOGNITION TO EVALUATE AND PREDICT POLLINATION
    Publication number: 20220237481
    Abstract: The exemplary embodiments disclose a method, a computer program product, and a computer system for evaluating the pollination of one or more crops, the method comprising collecting pollination data, extracting one or more features from the collected data, and evaluating a current state of pollination of the one or more crops based on the extracted one or more features and one or more models.
    Type: Application
    Filed: January 27, 2021
    Publication date: July 28, 2022
    Inventors: Steven Ware Jones, Jennifer A. Mallette, ZHENG XIE, Lisa Beth Lurie
  • Recombinant merozoite protein-1 p42 vaccine
    Patent number: 7150875
    Abstract: In this application is the expression and purification of a recombinant Plasmodium vivax (SalI) PvMSP-1 p42. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant PvMSP-1 p42 is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.
    Type: Grant
    Filed: March 18, 2002
    Date of Patent: December 19, 2006
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: David E. Lanar, Sheetij Dutta, Lisa A. Ware
  • Plasmodium falciparum AMA-1 protein and uses thereof
    Publication number: 20060264619
    Abstract: In this application is described the expression and purification of a recombinant Plasmodium falciparum (3D7) AMA-1 ectodomain. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant AMA-1 is useful as a diagnostic reagent, for use in antibody production, and as a protein for use alone, or as part of, a vaccine to prevent malaria.
    Type: Application
    Filed: January 13, 2006
    Publication date: November 23, 2006
    Inventors: David Lanar, Sheetij Dutta, Lisa Ware, Lalitha Nair
  • AMA-1 protein and uses thereof
    Patent number: 7060276
    Abstract: In this application is described the expression and purification of a recombinant Plasmodium falciparum (3D7) AMA-1 ectodomain. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant AMA-1 is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.
    Type: Grant
    Filed: March 25, 2002
    Date of Patent: June 13, 2006
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: David E. Lanar, Sheetij Dutta, Lisa A. Ware, Lalitha P. V. Nair
  • AMA-1 protein and uses thereof
    Patent number: 7029685
    Abstract: In this application is described the expression and purification of a recombinant Plasmodium falciparum (3D7) AMA-1 ectodomain. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant AMA-1 is useful as a diagnostic reagent, for use in antibody production, and as a protein for use alone, or as part of, a vaccine to prevent malaria.
    Type: Grant
    Filed: October 15, 2002
    Date of Patent: April 18, 2006
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: David E. Lanar, Sheetij Dutta, Lisa A. Ware, Lalitha P. V. Nair
  • Recombinant P. vivax merozoite protein-1 p42 vaccine
    Publication number: 20030157650
    Abstract: In this application is the expression and purification of a recombinant Plasmodium vivax (SalI) PvMSP-1 p42. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant PvMSP-1 p42 is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.
    Type: Application
    Filed: March 18, 2002
    Publication date: August 21, 2003
    Inventors: David E. Lanar, Sheetij Dutta, Lisa A. Ware
  • Plasmodium falciparum AMA-1 protein and uses thereof
    Publication number: 20030138450
    Abstract: In this application is described the expression and purification of a recombinant Plasmodium falciparum (3D7) AMA-1 ectodomain. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant AMA-1 is useful as a diagnostic reagent, for use in antibody production, and as a protein for use alone, or as part of, a vaccine to prevent malaria.
    Type: Application
    Filed: October 15, 2002
    Publication date: July 24, 2003
    Inventors: David E. Lanar, Sheetij Dutta, Lisa A. Ware, Lalitha P.V. Nair
  • Plasmodium falciparum AMA-1 protein and uses thereof
    Publication number: 20030032787
    Abstract: In this application is described the expression and purification of a recombinant Plasmodium falciparum (3D7) AMA-1 ectodomain. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant AMA-1 is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.
    Type: Application
    Filed: March 25, 2002
    Publication date: February 13, 2003
    Inventors: David E. Lanar, Sheetij Dutta, Lisa A. Ware, Lalitha P.V. Nair